Industries > Pharma > Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2013-2023
Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2013-2023
Pre-filled syringes and related devices – discover companies' revenue prospects
How are companies in the pre-filled syringe industry performing? Visiongain's report gives you data, analyses and discussions for producers of those drug delivery devices.
Our updated study lets you assess leading companies in the pre-filled (ready-to-fill) syringe industry and market, showing you their prospects to 2023. There you see financial results, interviews, trends, opportunities and revenue predictions.
That way, you discover information you need on established and emerging companies. Read on to scan those organisations and see what their future market could be worth.
See forecasts and discussions to help you stay ahead in knowledge
In our study you find analytical profiles of 15 top companies – and analyses of the overall industry – with historical data, revenue forecasts and growth rates. You also see qualitative analysis, business outlooks and developments. You gain 80 tables and 32 charts.
Our work lets you assess the most lucrative areas of those drug delivery technologies, seeing opportunities both for makers of drugs and of those medical injection devices.
That way you can stay ahead in knowledge of the industry and market for these medical devices:
• Plastic syringes
• Glass syringes
• Related injection products and disposable (single-use) systems for injecting drugs.
The following sections highlight what you find in our new study.
What you discover in our company profiles
Our report profiles 15 leading companies across four sectors of the pre-filled injection devices market. The content of each profile differs, depending on the company. In general, however, a profile contains the following information:
• Overview of the company, including its history in the pre-filled injection device market
• Discussions of the company's pre-filled injection device product/service portfolio, including an identification of main clients
• Analysis of the company's recent financial performance, for overall revenue and, where possible, pre-filled injection device revenue
• Assessment of its recent developments in the pre-filled injection device market, e.g. acquisitions, facility expansions, product launches and collaborations with the pharmaceutical industry
• Qualitative analysis of the company, identifying strengths over its competitors, as well as its opportunities for sales growth
• Prediction of revenue for the period 2013-2023 (for 10 of the 15 companies).
Also, in 2012 and 2013, Visiongain interviewed five of the 15 profiled companies. Those surveys cover how product and service demand for the companies has changed in recent years, as well as how that demand can change in coming years.
Those interviews include views on the development of the pre-filled syringe market. Our study also shows comparison and analysis of those interviews, summarising their lessons.
See prospects for leading pre-filled syringe manufacturers
Our study gives you discussions and financial analyses for leading producers of pre-filled syringes:
• Becton, Dickinson & Co. (BD)
• Nuova Ompi.
Discover what the future holds for those pharma-related medical device companies, seeing how they compare and compete. You see where the best prospects exist.
Suppliers and users of pre-filled injection systems will benefit from 2013 onwards. Next, our investigation analyses developers and producers of associated technologies.
What's the outlook for manufacturers of pre-filled syringe components?
Our report shows you developments and revenue prospects for leading producers of syringe components:
• Aptar Stelmi
• Datwyler Holding
• West Pharmaceutical Services.
There you see opportunities for companies making plungers, needle shields, tip caps and related products.
Our work shows you where sales growth can occur. Many opportunities remain, with expanding revenues possible from 2013 to 2023.
Find prospects for leading pen injector and autoinjector producers
In our study you also see commercial outlooks for top manufacturers of pen injectors and autoinjectors:
• Owen Mumford
• SHL Group
There you assess product portfolios, strategies and revenue prospects. You also investigate associated organisations and competition. Our work shows you possibilities for advancing technology and raising sales.
Who are the leading pre-filled syringe contract manufacturers?
Our work assesses contract manufacturing organisations (CMOs) in that field. There you discover activities of these prominent organisations:
• Hospira One2One
• Vetter Pharma.
There you also assess the competitive outlook for leading CMOs in that market. You also see discussions of biological drugs (biologics), lyophilisation and dual-chamber syringes.
Where is that overall area of drug delivery heading?
Our analysis predicts overall world revenues for those pre-filled injection devices – the drug delivery technology – will reach $4.47bn in 2017. These will expand further to 2023.
Greater use of biologics and vaccines will raise demand for parenteral delivery systems. Many opportunities exist, especially for plastic syringes and ready-to-use containment of labile drugs and other complex pharmaceuticals. Our study explains.
What about applications? The incidence of diabetes and expansion of the home healthcare market, in particular, will stimulate demand for pre-filled drug injection systems.
What about market needs? Medical injection systems giving improved clinical efficacy, safety and convenience will achieve commercial success this decade, our analyses show. See, then, prospects from 2013 to 2023 for that market and its leading companies.
Seven ways Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2013-2023 helps you
To sum up then, our investigation gives you the following knowledge:
• Revenues to 2023 for the overall world market and two product categories – you discover that industry's prospects, finding lucrative areas for investments and revenues
• Profiles of 15 leading companies – you assess products, services, sales results and outlooks, also gaining 10 revenue forecasts to 2023
• Interviews with 5 top companies in the industry – you discover debates and opinions to help you stay ahead
• Competition and opportunities – you see what affects that industry and shapes its future, especially needs for injecting biologics, biosimilars and other viscous drugs
• Discussions of technological progress and market expansion – you investigate developments, exploring possibilities for technological and commercial advances
• Analysis of what stimulates and restrains that industry and market – you assess challenges and strengths, helping you compete and gain advantages
• Prospects for established competitors and firms seeking to enter the sector – you explore needs, practices and outlooks for future success.
You gain information found nowhere else
That work gives independent analysis. There you receive business intelligence found only in our report, seeing where technological and financial prospects are most rewarding.
With our study you are less likely to fall behind in knowledge or miss opportunity. See there how you could benefit your research, analyses and decisions, also saving time and getting you recognition for technological and commercial insight.
Discover prospects for leading drug injection device companies by ordering now
Our investigation is for everyone needing analysis of the industry and market for drug delivery via injections. There you find data, trends, opportunities and predictions. Please order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
To view free sample pages of this report please click here